Yahoo · Sep 30, 2026
Nomination Committee of XVIVO Perfusion AB (publ)
The shareholders that have appointed the members of the nomination committee represented in aggregate 29.62 percent of all shares in the company as of 31 August 2026.
OTC · XVIPY
Xvivo Perfusion AB (publ)
Healthcare · Medical - Specialties
$5.50
Up+$0.00 (+0.00%)
Updated Oct 12, 2026, 9:10 PM
SID Score
3.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 579.59M
- P/E ratio
- 191.31
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 1K
- Avg. volume
- 314
Price performance · XVIPY
XVIPY price history
1M range · 0 trading sessions · Daily adjusted prices
XVIPY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest XVIPY news
The latest Smart Investors Daily articles mentioning XVIPY.
Stock researchCompany · Overview
Company
Market Activity
Research & News
XVIPY research
Overview
Company profile and research snapshot.
Company profile
XVIVO PERFUSION AB U/ADR
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 28, 2026 | STIFEL EUROPE | Buy | — |
| Jul 20, 2026 | PARETO SECURITIES AS | Buy | — |
| Jul 15, 2026 | HANDELSBANKEN CAPITAL MARKETS | Buy | — |
| Jul 15, 2026 | DNB CARNEGIE | Buy | — |
| Jul 14, 2026 | STIFEL EUROPE | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Sep 28, 2026
XVIVO Announces FDA Receipt of PMA Application for The XVIVO Heart Assist Transport System
CAUTION-Investigational device in the US. Limited by Federal (United States) law to investigational use.
SeekingAlpha · Sep 26, 2026
TransMedics Offers An Attractive Entry Point, With Upside Potential Outweighing Risks
TransMedics is a market-changing player in organ transplant technology, with a unique multi-organ perfusion platform. Read more on TMDX stock here.
Yahoo · Aug 3, 2026
XVIVO Granted Additional Patient Enrollment in the US PRESERVE CAP Study for XVIVO Heart Assist Transport
GOTHENBURG, SE / ACCESS Newswire / August 3, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - XVIVO announces that the US Food and Drug Administration (FDA) has granted the company approval for additional patient enrollment in the Continued ...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
